Market Panic Has Created 'Compelling' Opportunities In Biotech By: Benzinga via Benzinga August 25, 2015 at 13:06 PM EDT According to ROTH Capital Partners analyst Debjit Chattopadhyay, the recent market pullback has created some excellent buying ... Read More >> Related Stocks: Bluebird Bio Macrogenics Nektar Therapeutics Sarepta Therapeutics Uniqure Ord Shs